Literature DB >> 31202388

Common Mechanisms of Viral Injury to the Kidney.

Leslie A Bruggeman1.   

Abstract

Viral infections in an immunocompetent host can cause both acute and chronic kidney diseases, either by direct damage to the infected kidney cells or as a consequence of systemic immune responses that impact the kidneys' function. Viruses have evolved mechanisms to hijack signaling pathways of the infected cell, including the mammalian target of rapamycin pathway to support viral replication, and to evade antiviral immune responses such as those mediated by miR-155 via microRNA mimetics expressed by the virus. At both the cellular and systemic levels, the host has also evolved mechanisms to counter the viral subversion strategies in the evolutionary battle for mutual survival. In the era of genomic medicine, understanding individual genetic variations that lead to differences in susceptibilities to infection and variabilities in immune responses may open new avenues for treatment, such as the recently described functions of apolipoprotein L1 risk alleles in HIV-associated nephropathy. In addition, state-of-the-art high-throughput sequencing methods have discovered new viruses as the cause for chronic diseases not previously attributed to an infection. The potential application of these methods to idiopathic kidney diseases may reveal similar occult infections by unknown viruses. Precision medicine objectives to optimize host-directed and pathogen-directed therapies for kidney diseases associated with infectious causes will only be achieved through detailed understanding of genetic susceptibility associated with immune responses and viral tropism.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Gene-environment interactions; Innate immunity; Next-generation sequencing; Viruses

Mesh:

Substances:

Year:  2019        PMID: 31202388      PMCID: PMC6578596          DOI: 10.1053/j.ackd.2018.12.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  59 in total

1.  Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

Authors:  J A Winston; L A Bruggeman; M D Ross; J Jacobson; L Ross; V D D'Agati; P E Klotman; M E Klotman
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

2.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

3.  Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.

Authors:  L A Bruggeman; S Dikman; C Meng; S E Quaggin; T M Coffman; P E Klotman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

Review 4.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

5.  The innate immune factor apolipoprotein L1 restricts HIV-1 infection.

Authors:  Harry E Taylor; Atanu K Khatua; Waldemar Popik
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

6.  APOL1 variants may induce HIV-associated nephropathy during HIV primary infection.

Authors:  Marine De Laroche; Geoffroy Desbuissons; Philippe Rouvier; Francis Barin; Gilbert Deray; Eric Caumes; Christine Katlama; Roland Tubiana; Corinne Isnard Bagnis
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

7.  Human cytomegalovirus infection maintains mTOR activity and its perinuclear localization during amino acid deprivation.

Authors:  Amy J Clippinger; Tobi G Maguire; James C Alwine
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.

Authors:  Johanna R Abend; Dhivya Ramalingam; Philippe Kieffer-Kwon; Thomas S Uldrick; Robert Yarchoan; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

9.  Critical role for Nef in HIV-1-induced podocyte dedifferentiation.

Authors:  Masaaki Sunamoto; Mohammad Husain; John Cijiang He; Elissa J Schwartz; Paul E Klotman
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

Review 10.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29
View more
  2 in total

1.  Coronavirus disease 2019: acute Fanconi syndrome precedes acute kidney injury.

Authors:  Raphaël Kormann; Audrey Jacquot; Asma Alla; Alice Corbel; Matthieu Koszutski; Paul Voirin; Matthieu Garcia Parrilla; Sybille Bevilacqua; Evelyne Schvoerer; Jean-Louis Gueant; Farès Namour; Bruno Levy; Luc Frimat; Abderrahim Oussalah
Journal:  Clin Kidney J       Date:  2020-06-08

2.  Inhibitory effect of anti-malarial agents on the expression of proinflammatory chemokines via Toll-like receptor 3 signaling in human glomerular endothelial cells.

Authors:  Riko Sato; Tadaatsu Imaizumi; Tomomi Aizawa; Shojiro Watanabe; Koji Tsugawa; Shogo Kawaguchi; Kazuhiko Seya; Tomoh Matsumiya; Hiroshi Tanaka
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.